Updated Jul 16, 2026
GENDRON PAUL ANDREW has filed 2 SEC Form 4 filings across 1 company in the last 90 days — buying. Lifetime open-market purchases: $44K.
Paul Andrew Gendron is listed as a director of InfuSystem Holdings, Inc. in SEC filings as of May 12, 2026. Beyond this board appointment, public biographical details are not provided in the given SEC context. His directorship indicates board-level governance involvement with InfuSystem.
| Role | Director |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-12 | INFU | InfuSystem Holdings, Inc | P — Open-market purchase | 5.0K | $8.88 | $44K |
Paul Andrew Gendron is listed as a director of InfuSystem Holdings, Inc. in SEC filings as of May 12, 2026. Beyond this board appointment, public biographical details are not provided in the given SEC context. His directorship indicates board-level governance involvement with InfuSystem.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($44K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live GENDRON PAUL ANDREW profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.